Strata Critical Medical, Inc.
SRTA
$4.34
$0.040.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 66.95% | 17.50% | 71.15% | -- |
| Total Depreciation and Amortization | -- | 13.92% | 6.46% | -15.28% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -58.24% | 210.84% | -72.35% | -- |
| Change in Net Operating Assets | -- | -190.03% | 106.01% | 130.00% | -- |
| Cash from Operations | -686.89% | -136.35% | 98.42% | 81.20% | 214.14% |
| Capital Expenditure | -- | 85.78% | -220.96% | -18,995.83% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -94.93% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 4,249.66% | -9.29% | 22,028.21% | -- |
| Cash from Investing | 118.96% | 269.62% | -16.92% | 5,201.33% | -316.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -36.36% | -34.07% | 528.57% | -- |
| Repurchase of Common Stock | -- | 6.42% | -11,537.84% | -12,960.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -144.46% | 5.88% | -7,962.96% | -16,743.48% | -12,083.33% |
| Foreign Exchange rate Adjustments | -- | 2,257.14% | 584.62% | -826.67% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -435.95% | 354.07% | 77.46% | 80.99% | -521.98% |